← Leaderboards
William A Clark
Pbl Biomedical Laboratories
$1,565,882
Attributed
$1,565,882
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,565,882 · 3
By mechanism
R44$1,101,639 · 1
R43$464,243 · 2
Top collaborators
No co-investigators on record.
Most similar at Pbl Biomedical Laboratories
Same institution · by research overlap
- Doranelly Philipova$100,000
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionProtein EngineeringMonoclonal AntibodyTissue /Cell CultureTumor AntigensBiotechnologyBiotherapeutic AgentImmunologic Substance Development /PreparationLaboratory MouseNeoplasm /Cancer ImmunotherapyNeoplastic CellPhosphorylationRadionuclidesAntigen Antibody ReactionMolecular CloningGreen Fluorescent ProteinsProtein Protein InteractionCytokine ReceptorsHuman T Cell LeukemiaReceptor ExpressionInterferon GammaInterleukin 10Intermolecular InteractionFluorescence Resonance Energy Transfer
Grant awards (4)
Phosphorylatable (33P)IL-2 &Anti-Tac MAb in ATL Therapy$287,840
R43 · FY2005 · CA
Phosphorylatable Monoclonal Antibodies for Tumor Therapy$346,630
R44 · FY2003 · CA
Assessing Protein Interactions in Cells by Fluorescence$176,403
R43 · FY2003 · GM
Phosphorylatable Monoclonal Antibodies for Tumor Therapy$755,009
R44 · FY2002 · CA